CBE ID
1522
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description
Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.
Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
1.9 Care Setting
1.20 Types of Data Sources
Numerator
1.14 Numerator
Count of patients with ACE-I or ARB therapy prescribed at discharge.
Denominator
1.15 Denominator
1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
AND
2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented
Exclusions
Exclusions
Discharge status of expired
Contraindicated or blinded to both ACE inhibitors and ARB therapy
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Cardiovascular Project 2015-2016
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
American College of Cardiology
Steward POC email
Steward Organization Copyright
© 2010 American College of Cardiology Foundation All Rights Reserved
Importance
Care Gaps
Feasibility
Scientific Acceptability
Risk Adjustment
Risk Adjustment
Use & Usability
Use
Planned Use
6.1.2 Current or Planned Use(s)
Public Comments